Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSERA: Dose Reduction or Discontinuation of Etanercept in Methotrexate-Treated Rheumatoid Arthritis
2007-006657-63Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2009
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etanercept in rheumatoid arthritis (RA) (3 arms), sponsored by Pfizer. Started Jan 2009; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-006657-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006657-63.